Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
F Washington, D Langdon - Journal of neurology, 2022 - Springer
People with multiple sclerosis (MS) face challenges adhering to disease-modifying drug
(DMD) treatment. Poor adherence to treatment reduces its clinical effectiveness which can …
(DMD) treatment. Poor adherence to treatment reduces its clinical effectiveness which can …
Adherence to therapy in patients with multiple sclerosis
A Kołtuniuk, J Chojdak-Łukasiewicz - International Journal of …, 2022 - mdpi.com
Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central
nervous system (CNS). MS is an incurable disease. The goal of disease-modifying therapies …
nervous system (CNS). MS is an incurable disease. The goal of disease-modifying therapies …
An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug
Objective As the multiple sclerosis (MS) disease-modifying drug (DMD) treatment options
have expanded to include oral therapies, it is important to understand whether route of …
have expanded to include oral therapies, it is important to understand whether route of …
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: a real-life study
Background: With many options now available, first therapy choice is challenging in multiple
sclerosis (MS) and depends mainly on neurologist and patient preferences. Objectives: To …
sclerosis (MS) and depends mainly on neurologist and patient preferences. Objectives: To …
Formative and validation human factors studies of a new disposable prefilled injection device for subcutaneous delivery of acthar gel (repository corticotropin injection)
A Linnane, M Lau, P Miranda… - Expert Opinion on Drug …, 2024 - Taylor & Francis
Background The administration of repository corticotropin injection (Acthar Gel) via a single-
dose prefilled injector (SelfJect) is intended to provide a simple, ergonomic alternative to …
dose prefilled injector (SelfJect) is intended to provide a simple, ergonomic alternative to …
Objective medication adherence and persistence in people with multiple sclerosis: a systematic review, meta-analysis, and meta-regression
J Mardan, MA Hussain, M Allan, LB Grech - Journal of Managed Care & …, 2021 - jmcp.org
BACKGROUND: Medication adherence is critical for the realization of pharmacotherapy
benefits and reduced healthcare expenditure. Studies have shown up to 60% of people with …
benefits and reduced healthcare expenditure. Studies have shown up to 60% of people with …
Connected drug delivery devices to complement drug treatments: potential to facilitate disease management in home setting
B Bittner, C Schmit Chiesi, S Kharawala… - Medical Devices …, 2019 - Taylor & Francis
Connected drug delivery devices are increasingly being developed to support patient
supervision and counseling in home setting. Features may include dosing reminders …
supervision and counseling in home setting. Features may include dosing reminders …
Recent developments in interferon-based therapies for multiple sclerosis
L Dumitrescu, CS Constantinescu… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Multiple sclerosis (MS) is a chronic and disabling immune-mediated disease of
the central nervous system. Beta-interferons are the first approved and still the most widely …
the central nervous system. Beta-interferons are the first approved and still the most widely …
Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature Review
AB Ben-Zacharia, B Walker, AP Ross… - … Journal of MS …, 2023 - meridian.allenpress.com
ABSTRACT BACKGROUND Patients with multiple sclerosis (MS) receiving disease-
modifying therapies (DMT) show published adherence rates of 27.0% to 93.8% and …
modifying therapies (DMT) show published adherence rates of 27.0% to 93.8% and …
A multicenter, observational, prospective study of self-and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a …
Besides the impact of disease per se, the use of immunomodulatory therapies in
adolescents with relapsing-remitting multiple sclerosis (RRMS) may have an effect on …
adolescents with relapsing-remitting multiple sclerosis (RRMS) may have an effect on …